These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9033806)

  • 1. Intracellular targets for nitric oxide toxicity to pancreatic beta-cells.
    Delaney CA; Eizirik DL
    Braz J Med Biol Res; 1996 May; 29(5):569-79. PubMed ID: 9033806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines, nitric oxide and insulin secreting cells.
    Cunningham JM; Green IC
    Growth Regul; 1994 Dec; 4(4):173-80. PubMed ID: 7756973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
    Reimers JI
    Dan Med Bull; 1998 Apr; 45(2):157-80. PubMed ID: 9587701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage and cytotoxicity in pancreatic beta-cells expressing human CYP2E1.
    Lees Murdock DJ; Barnett YA; Barnett CR
    Biochem Pharmacol; 2004 Aug; 68(3):523-30. PubMed ID: 15242818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for c-Jun N-terminal kinase in beta-cell recovery from nitric oxide-mediated damage.
    Scarim AL; Nishimoto SY; Weber SM; Corbett JA
    Endocrinology; 2003 Aug; 144(8):3415-22. PubMed ID: 12865320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interleukin-1 and nitric oxide involved in the pathogenesis of diabetes)].
    Sjöholm A
    Lakartidningen; 1999 May; 96(19):2338-41. PubMed ID: 10377681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells.
    Ankarcrona M; Dypbukt JM; Brüne B; Nicotera P
    Exp Cell Res; 1994 Jul; 213(1):172-7. PubMed ID: 8020588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death.
    Delaney CA; Tyrberg B; Bouwens L; Vaghef H; Hellman B; Eizirik DL
    FEBS Lett; 1996 Oct; 394(3):300-6. PubMed ID: 8830662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and pancreatic beta-cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer.
    Welsh N; Eizirik DL; Sandler S
    Autoimmunity; 1994; 18(4):285-90. PubMed ID: 7858114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI; Eizirik DL
    Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide inhibits IRF-1 mRNA induction and prevents IL-1 beta-induced nitric oxide synthase expression in pancreatic beta cells.
    Akabane A; Kato I; Takasawa S; Unno M; Yonekura H; Yoshimoto T; Okamoto H
    Biochem Biophys Res Commun; 1995 Oct; 215(2):524-30. PubMed ID: 7487987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.
    Flodström M; Eizirik DL
    Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell defence and repair mechanisms in human pancreatic islets.
    Eizirik DL
    Horm Metab Res; 1996 Jun; 28(6):302-5. PubMed ID: 8811335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA.
    Dunger A; Augstein P; Schmidt S; Fischer U
    J Autoimmun; 1996 Jun; 9(3):309-13. PubMed ID: 8816965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
    Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
    Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the citrulline-nitric oxide cycle in rodent and human pancreatic beta-cells: induction of argininosuccinate synthetase by cytokines.
    Flodström M; Niemann A; Bedoya FJ; Morris SM; Eizirik DL
    Endocrinology; 1995 Aug; 136(8):3200-6. PubMed ID: 7628352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of nitric oxide on the functional change of interleukin-1 beta and interleukin-6 induced rat pancreatic islets of Langerhans].
    Chen H; Cai D; Wang M; Liu H
    Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):458-61. PubMed ID: 11798681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways.
    Matsuda T; Ferreri K; Todorov I; Kuroda Y; Smith CV; Kandeel F; Mullen Y
    Endocrinology; 2005 Jan; 146(1):175-85. PubMed ID: 15459112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
    Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
    J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.